Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 3
1968 2
1970 1
1971 8
1972 55
1973 111
1974 171
1975 181
1976 243
1977 313
1978 313
1979 304
1980 123
1981 135
1982 89
1983 81
1984 90
1985 84
1986 76
1987 60
1988 51
1989 63
1990 62
1991 68
1992 61
1993 57
1994 55
1995 65
1996 65
1997 71
1998 74
1999 76
2000 90
2001 95
2002 84
2003 81
2004 84
2005 88
2006 112
2007 100
2008 135
2009 115
2010 131
2011 139
2012 162
2013 168
2014 204
2015 199
2016 203
2017 223
2018 215
2019 134
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

5,704 results
Results by year
Filters applied: . Clear all
Page 1
Fc-fusion Proteins in Therapy: An Updated View.
Jafari R, Zolbanin NM, Rafatpanah H, Majidi J, Kazemi T. Jafari R, et al. Curr Med Chem. 2017;24(12):1228-1237. doi: 10.2174/0929867324666170113112759. Curr Med Chem. 2017. PMID: 28088904 Review.
Conformational Plasticity of the Immunoglobulin Fc Domain in Solution.
Remesh SG, Armstrong AA, Mahan AD, Luo J, Hammel M. Remesh SG, et al. Structure. 2018 Jul 3;26(7):1007-1014.e2. doi: 10.1016/j.str.2018.03.017. Epub 2018 May 3. Structure. 2018. PMID: 29731233 Free PMC article.
Fcγ Receptor Function and the Design of Vaccination Strategies.
Bournazos S, Ravetch JV. Bournazos S, et al. Immunity. 2017 Aug 15;47(2):224-233. doi: 10.1016/j.immuni.2017.07.009. Immunity. 2017. PMID: 28813656 Free PMC article. Review.
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riddle MC, Rydén L, Xavier D, Atisso CM, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona-Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw J, Sheu WH, Temelkova-Kurktschiev T; REWIND Trial Investigators. Gerstein HC, et al. Diabetes Obes Metab. 2018 Jan;20(1):42-49. doi: 10.1111/dom.13028. Epub 2017 Jul 14. Diabetes Obes Metab. 2018. PMID: 28573765 Free article.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial.
Pratley RE, Aroda VR, Lingvay I, Lüdemann J, Andreassen C, Navarria A, Viljoen A; SUSTAIN 7 investigators. Pratley RE, et al. Lancet Diabetes Endocrinol. 2018 Apr;6(4):275-286. doi: 10.1016/S2213-8587(18)30024-X. Epub 2018 Feb 1. Lancet Diabetes Endocrinol. 2018. PMID: 29397376 Clinical Trial.
5,704 results
Jump to page
Feedback